CHTP cuts executive pay 25 percent, suspends bonuses to pay for trials
Drug developers typically turn to investors to finance clinical work on drug candidates. Chelsea Therapeutics (NASDAQ:CHTP) executives and directors are slashing their own paychecks to help pay for...
View ArticleLess than 1% of HGSI shares tendered for sale; GSK extends $2.6B offer
GlaxoSmithKline‘s (NYSE:GSK) $2.6 billion offer to buy Human Genome Sciences (NASDAQ:HGSI) has enticed holders of 474,029 shares of the Maryland biotechnology company to tender their stock for the...
View ArticleExperimental lupus therapy from Argos in partnering talks after strong phase 1
A dendritic cell The experimental lupus treatment being developed by Argos Therapeutics is showing promise in early stage clinical trials, but the questions remain whether it’s enough progress to...
View ArticleWhat globalization and outsourcing issues keep you up at night?
Taking advantage of global opportunities while keeping costs low are the dual targets of many companies. Yet, globalization and outsourcing contain inherent perils. So when a group of global medical...
View ArticlePharma reviving Boehringer’s female sexual dysfunction drug gets $17.6M
Using a compound that Boehringer Ingelheim abandoned two years ago, Sprout Pharmaceuticals is taking a $20 million step toward developing a drug therapy specifically for hypoactive sexual desire...
View ArticleRex Health Ventures’ inaugural investment goes to RTP firm developing...
A $10 million venture fund launched earlier this year by the private, nonprofit hospital Rex Healthcare has found its first portfolio company in Morrisville, North Carolina-based Aerial BioPharma,...
View ArticleQuintiles software deal with Allscripts seeks to clear up clinical trial...
Quintiles is collaborating with electronic health records firm Allscripts Healthcare Solutions (NASDAQ:MDRX) to develop software to streamline the process of setting up and recruiting for clinical...
View ArticleHealthcare idea hub collaborating with public hospital group seeks entrepreneurs
A product development business has made a big move into healthcare, collaborating with the second-largest public hospital group in the country to launch a healthcare and medical device innovation...
View ArticleMerck boosts HIV drug portfolio in two licensing deals
HIV Merck (NYSE:MRK) has acquired a late-stage drug to treat HIV infection in a licensing deal valued at more than $168 million. It also acquired an early stage drug from a Japanese pharmaceutical...
View Article2 reasons for optimism right now in university technology transfer
From commercialization partnerships to startup incubators and new sources of funding, universities seem to be getting creative in how they’re breathing innovative thinking into their technology...
View Article5 things that have influenced pharmaceutical digital marketing expansion
Pharmaceutical companies have been increasing their investment in digital marketing strategies including websites, e-marketing and social media, despite the potential risks that lurk just below the...
View ArticleFirm with tag system for detecting counterfeit drugs raising $600K
Company name: CertiRx Corp. Industry: pharmaceuticals (other). Location: Research Triangle Park, North Carolina. Solution/product: To prevent counterfeiting and fraud in pharmaceuticals and other...
View ArticleDuke’s research, startup’s mobile messaging platform meet in joint venture...
A new mobile health startup is bringing together industry and academia to help providers and payers address patient non-compliance. Improved Patient Outcomes Inc. (IPO) is a new joint venture spun...
View ArticleGSK moving ahead with ‘proof of concept’ tuberculosis vaccine
LONDON (Reuters) - GlaxoSmithKline and the non-profit biotech group Aeras are to assess an experimental tuberculosis vaccine in "proof of concept" tests in Africa and India, marking a step forward in...
View ArticleGSK will open up drug data; information includes patient data on failed trials
LONDON (Reuters) - GlaxoSmithKline, criticized in the past for keeping important information about its medicines under wraps, is to lift the lid on more of its drug secrets. Chief executive Andrew...
View ArticleAetna, UNC Health Care settle disagreements and sign new deal
Aetna and the UNC Health Care system have settled their differences. The insurer and UNC Health severed ties in February, 2011, after contract negotiations failed. UNC wanted more money from Aetna to...
View ArticleHow popular could on-site mammograms become as an employee perk?
A photo of N.C. State University Women's Basketball Coach Kay Yow, who died in 2009 after battling cancer, smiles down from the side of a petal-pink van adorned with her quote, "Never let the urgent...
View ArticleSeed round will help radiation therapy startup prevent harmful effects of...
One of the most common and most disruptive drawbacks of existing cancer chemotherapies is the toxic effect of bone marrow suppression that can result from a patient’s exposure to ionized radiation....
View ArticleOnline clinical trial recruitment study assesses patient reliability
One of the biggest hurdles in advancing online patient recruitment is this — can potential patient participants be relied upon to provide accurate information? And can recruitment efforts skip over...
View ArticleTranzyme stomach paralysis drug is tripped up at mid-stage trial
(Reuters) - Tranzyme Inc said a preliminary analysis showed that its experimental drug to treat a type of paralysis of the stomach did not meet the main goal of a mid-stage trial. The main goal of the...
View Article
More Pages to Explore .....